The PI3K/AKT/mTOR pathway is an intracellular signaling pathway important in regulating the cell cycle. Therefore, it is directly related to cellular quiescence, proliferation, cancer, and longevity. PI3K activation phosphorylates and activates AKT, localizing it in the plasma membrane. AKT can have a number of downstream effects such as activating CREB, inhibiting p27, localizing FOXO in the cytoplasm, activating PtdIns-3ps, and activating mTOR which can affect transcription of p70 or 4EBP1. There are many known factors that enhance the PI3K/AKT pathway including EGF, shh, IGF-1, insulin, and CaM. The pathway is antagonized by various factors including PTEN, GSK3B, and HB9. In many cancers, this pathway is overactive, thus reducing apoptosis and allowing proliferation. This pathway is necessary, however, to promote growth and proliferation over differentiation of adult stem cells, neural stem cells specifically. It is the difficulty in finding an appropriate amount of proliferation versus differentiation that researchers are trying to determine in order to utilize this balance in the development of various therapies.
SC-514是IKK-2特异性抑制剂,IC50为11.2uM,对IKK其它亚型或别的丝氨酸-苏氨酸和酪氨酸激酶无抑制性。
MoreWS6是促β细胞增生的新型小分子,在啮齿类动物和人源原发性胰岛中EC50值为0.28uM。
MoreLY2409881三盐酸盐是IKK2高效选择性抑制剂,IC50值为30nM,对IKK1和其他激酶抑制力弱。
MoreBardoxolone Methyl是一种IKK抑制剂,具有强效的促凋亡和抗炎活性。
MoreWS3是促β)细胞增生的新型小分子,在诱导R7T1细胞增殖实验中EC50值为28nM。
More